{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:47:12Z","timestamp":1791301632815,"version":"4.1.0"},"reference-count":38,"publisher":"Impact Journals, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,10]]},"DOI":"10.18632\/oncotarget.13849","type":"journal-article","created":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T15:24:35Z","timestamp":1481383475000},"page":"3495-3508","source":"Crossref","is-referenced-by-count":31,"title":["Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model"],"prefix":"10.18632","volume":"8","author":[{"given":"Christine C.","family":"Dobson","sequence":"first","affiliation":[{"name":"Molecular Biomedicine Program, Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada"},{"name":"Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thet","family":"Naing","sequence":"additional","affiliation":[{"name":"Molecular Biomedicine Program, Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn T.","family":"Beug","sequence":"additional","affiliation":[{"name":"Molecular Biomedicine Program, Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mame D.","family":"Faye","sequence":"additional","affiliation":[{"name":"Molecular Biomedicine Program, Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle","family":"Chabot","sequence":"additional","affiliation":[{"name":"Molecular Biomedicine Program, Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"St-Jean","sequence":"additional","affiliation":[{"name":"Molecular Biomedicine Program, Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle E.","family":"Walker","sequence":"additional","affiliation":[{"name":"Molecular Biomedicine Program, Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"LaCasse","sequence":"additional","affiliation":[{"name":"Molecular Biomedicine Program, Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Stojdl","sequence":"additional","affiliation":[{"name":"Molecular Biomedicine Program, Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada"},{"name":"Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Korneluk","sequence":"additional","affiliation":[{"name":"Molecular Biomedicine Program, Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada"},{"name":"Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Holcik","sequence":"additional","affiliation":[{"name":"Molecular Biomedicine Program, Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada"},{"name":"Department of Pediatrics, University of Ottawa, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,12,10]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11912-010-0130-3","article-title":"Childhood rhabdomyosarcoma: new insight on biology and treatment","volume":"12","author":"Skapek","year":"2010","journal-title":"Current oncology reports"},{"key":"2","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1111\/febs.12421","article-title":"Mechanisms of impaired differentiation in rhabdomyosarcoma","volume":"280","author":"Guttridge","year":"2013","journal-title":"The FEBS journal"},{"key":"3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1634\/theoncologist.4-1-34","article-title":"Rhabdomyosarcoma: an overview","volume":"4","author":"Helman","year":"1999","journal-title":"The oncologist"},{"key":"4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/pbc.24118","article-title":"Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies","volume":"59","author":"Hawkins","year":"2012","journal-title":"Pediatric blood & cancer"},{"key":"5","first-page":"187","article-title":"Systemic treatment of soft-tissue sarcoma-gold standard and novel therapies. Nature reviews","volume":"11","author":"Benson","year":"2014","journal-title":"Clinical oncology"},{"key":"6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2174\/156800908785699333","article-title":"Targeting apoptosis resistance in rhabdomyosarcoma","volume":"8","author":"Fulda","year":"2008","journal-title":"Current cancer drug targets"},{"key":"7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semcdb.2014.12.005","article-title":"Smac mimetics as IAP antagonists","volume":"39","author":"Fulda","year":"2015","journal-title":"Seminars in cell & developmental biology"},{"key":"8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1387\/ijdb.150084el","article-title":"Combinatorial cancer immunotherapy strategies with proapoptotic small-molecule IAP antagonists","volume":"59","author":"Lacasse","year":"2015","journal-title":"The International journal of developmental biology"},{"key":"9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrc2889","article-title":"IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer","volume":"10","author":"Meier","year":"2010","journal-title":"Nature reviews. Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.molcel.2008.02.012","article-title":"Quantitative analysis of pathways controlling extrinsic apoptosis in single cells","volume":"30","author":"Sorger","year":"2008","journal-title":"Molecular cell"},{"key":"11","doi-asserted-by":"crossref","first-page":"e28541","DOI":"10.4161\/onci.28541","article-title":"Smac mimetics combined with innate immune stimuli create the perfect cytokine storm to kill tumor cells","volume":"3","author":"Korneluk","year":"2014","journal-title":"Oncoimmunology"},{"key":"12","first-page":"1471","volume-title":"Science","volume":"305","author":"Harran","year":"2004"},{"key":"13","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/onc.2014.90","article-title":"IGF2BP1 controls cell death and drug resistance in rhabdomyosarcomas by regulating translation of cIAP1","volume":"34","author":"Holcik","year":"2015","journal-title":"Oncogene"},{"key":"14","doi-asserted-by":"crossref","first-page":"34853","DOI":"10.1074\/jbc.M205149200","article-title":"Endogenous membrane tumor necrosis factor (TNF) is a potent amplifier of TNF receptor 1-mediated apoptosis","volume":"277","author":"Wajant","year":"2002","journal-title":"The Journal of biological chemistry"},{"key":"15","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/pbc.23167","article-title":"Initial testing (stage 1) of LCL161, a SMAC mimetic, by the Pediatric Preclinical Testing Program","volume":"58","author":"Smith","year":"2012","journal-title":"Pediatric blood & cancer"},{"key":"16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nbt.2806","article-title":"Smac mimetics and innate immune stimuli synergize to promote tumor death","volume":"32","author":"Ilkow","year":"2014","journal-title":"Nature biotechnology"},{"key":"17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/bjc.2013.335","article-title":"IRF-1 responsiveness to IFN-gamma predicts different cancer immune phenotypes","volume":"109","author":"Wang","year":"2013","journal-title":"British journal of cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"e1002230","DOI":"10.1371\/journal.ppat.1002230","article-title":"Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infection","volume":"7","author":"Diamond","year":"2011","journal-title":"PLoS pathogens"},{"key":"19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/0022034511421490","article-title":"Childhood rhabdomyosarcoma: recent advances and prospective views","volume":"91","author":"Wang","year":"2012","journal-title":"Journal of dental research"},{"key":"20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrd3627","article-title":"Targeting IAP proteins for therapeutic intervention in cancer. Nature reviews","volume":"11","author":"Vucic","year":"2012","journal-title":"Drug discovery"},{"key":"21","doi-asserted-by":"crossref","first-page":"40612","DOI":"10.1074\/jbc.M110.183616","article-title":"Smac mimetic compounds potentiate interleukin-1beta-mediated cell death","volume":"285","author":"Korneluk","year":"2010","journal-title":"The Journal of biological chemistry"},{"key":"22","article-title":"An immunologic portrait of cancer","volume":"9","author":"Marincola","year":"2011","journal-title":"Journal of translational medicine"},{"key":"23","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs. Nature reviews","volume":"14","author":"Zloza","year":"2015","journal-title":"Drug discovery"},{"key":"24","doi-asserted-by":"crossref","first-page":"e1758","DOI":"10.1038\/cddis.2015.122","article-title":"IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity","volume":"6","author":"Kumar","year":"2015","journal-title":"Cell death & disease"},{"key":"25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jgm.999","article-title":"Development of a second-generation oncolytic Herpes simplex virus expressing TNFalpha for cancer therapy","volume":"9","author":"Coffin","year":"2007","journal-title":"The journal of gene medicine"},{"key":"26","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.18632\/oncotarget.6915","article-title":"Cooperative TRAIL production mediates IFNalpha\/Smac mimetic-induced cell death in TNFalpha-resistant solid cancer cells","volume":"7","author":"Fulda","year":"2016","journal-title":"Oncotarget"},{"key":"27","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1002\/lary.25056","article-title":"Combination effects of SMAC mimetic birinapant with TNFalpha, TRAIL, and docetaxel in preclinical models of HNSCC","volume":"125","author":"Van Waes","year":"2015","journal-title":"The Laryngoscope"},{"key":"28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/cgt.2015.11","article-title":"Oncolytic viruses: focusing on the tumor microenvironment","volume":"22","author":"Lattime","year":"2015","journal-title":"Cancer gene therapy"},{"key":"29","doi-asserted-by":"publisher","first-page":"22174","DOI":"10.18632\/oncotarget.7907","article-title":"Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer","volume":"7","author":"Bartlett","year":"2016","journal-title":"Oncotarget"},{"key":"30","article-title":"To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses","volume":"8","author":"Cripe","year":"2016","journal-title":"Viruses"},{"key":"31","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nm.3848","article-title":"Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity","volume":"21","author":"Alkayyal","year":"2015","journal-title":"Nature medicine"},{"key":"32","first-page":"143","article-title":"Combination cancer immunotherapies tailored to the tumour microenvironment. Nature reviews","volume":"13","author":"Teng","year":"2016","journal-title":"Clinical oncology"},{"key":"33","doi-asserted-by":"crossref","first-page":"237ra67","DOI":"10.1126\/scitranslmed.3007974","article-title":"Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy","volume":"6","author":"Mackall","year":"2014","journal-title":"Science translational medicine"},{"key":"34","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ijc.21155","article-title":"CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction","volume":"117","author":"Salvi","year":"2005","journal-title":"International journal of cancer"},{"key":"35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1189\/jlb.1212631","article-title":"At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy","volume":"94","author":"Wolchok","year":"2013","journal-title":"Journal of leukocyte biology"},{"key":"36","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bcp.2012.04.023","article-title":"Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells","volume":"84","author":"Cheng","year":"2012","journal-title":"Biochemical pharmacology"},{"key":"37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1535-6108(03)00241-1","article-title":"VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents","volume":"4","author":"Durbin","year":"2003","journal-title":"Cancer cell"},{"key":"38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2164-3-5","article-title":"Cloning and characterization of the rat homologues of the Inhibitor of Apoptosis protein 1, 2, and 3 genes","volume":"3","author":"Korneluk","year":"2002","journal-title":"BMC Genomics"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T12:58:17Z","timestamp":1594817897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,10]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1,10]]}},"alternative-id":["13849","27966453"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13849","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727107848.793530875","asserted-by":"object"}]},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,10]]}}}